74 related articles for article (PubMed ID: 21327940)
21. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
Gocheva L; Koleva I
Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
[TBL] [Abstract][Full Text] [Related]
22. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
23. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
24. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
25. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
Cuttner J; Spiera H; Troy K; Wallenstein S
J Rheumatol; 2005 Oct; 32(10):1884-7. PubMed ID: 16206341
[TBL] [Abstract][Full Text] [Related]
27. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
29. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
[TBL] [Abstract][Full Text] [Related]
30. Adult malignant lymphomas in University of Benin Teaching Hospital, Benin City, Nigeria--incidence and survival.
Omoti CE; Halim NK
Niger J Clin Pract; 2007 Mar; 10(1):10-4. PubMed ID: 17668708
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas.
Tirelli U; Errante D; Spina M; Vaccher E; Serraino D; Boiocchi M; Gloghini A; Carbone A
Hematol Oncol; 1996 Mar; 14(1):7-15. PubMed ID: 8613137
[TBL] [Abstract][Full Text] [Related]
32. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
33. Medical history and the risk of non-Hodgkin's lymphomas.
La Vecchia C; Negri E; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):533-6. PubMed ID: 1302565
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
Yun J; Kim SJ; Kim JA; Kong JH; Lee SH; Kim K; Ko YH; Kim WS
Acta Haematol; 2010; 123(1):48-54. PubMed ID: 19955711
[TBL] [Abstract][Full Text] [Related]
36. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from China.
Hu S; Zhou D; Wu Y; Zhao Y; Wang S; Han B; Duan M; Li J; Zhu T; Zhuang J; Cao X; Cai H; Feng J; Zhang Y; Zhang F; Zeng X; Zhao Y; Wang Q; Zhang W
Ann Hematol; 2019 Feb; 98(2):445-455. PubMed ID: 30370485
[TBL] [Abstract][Full Text] [Related]
38. General features and epidemiology of lymphoma in Colombia. A multicentric study.
Combariza JF; Lombana M; Torres AM; Castellanos AM; Arango M
Ann Hematol; 2015 Jun; 94(6):975-80. PubMed ID: 25645655
[TBL] [Abstract][Full Text] [Related]
39. Acquired disorders affecting the immune system and non-Hodgkin's lymphoma.
Tielsch JM; Linet MS; Szklo M
Prev Med; 1987 Jan; 16(1):96-106. PubMed ID: 3823013
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.
Jachiet V; Mekinian A; Carrat F; Grignano E; Retbi A; Boffa JJ; Ronco P; Rondeau E; Sellam J; Berenbaum F; Chazouillères O; Capron J; Alamowitch S; Chasset F; Frances C; Coppo P; Fain O;
Leuk Lymphoma; 2018 Jun; 59(6):1399-1405. PubMed ID: 28972423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
